Skip to main content

Day: February 28, 2024

Taboola Reports Strong Q4 Net Income and Adj. EBITDA; Profits Beat High End of Guidance for Q4 and FY 2023; 2024 Guidance Calls for Record Year With Substantial Growth Across All Key Metrics

Key Highlights2023 Financials – strong exiting momentum sets Taboola up for great 2024Q4 2023 Revenue +13%, Gross profit +4%, and ex-TAC Gross Profit +6% inline with guidance midpoint (including small impact from changes to Microsoft’s ad platform) Q4 2023 strong Net income, and Adj. EBITDA beat above high end of guidance range2024 Financials – step function top line growth and massive Adj. EBITDA/margin growth2024 step function growth / record year: ~$2B in Revenue (+33% YoY), ~$545M Gross profit (+28% YoY), ~$670M ex-TAC Gross Profit (+25% YoY), $200M+ Adj. EBITDA (2x+ YoY), $100M+ Free Cash Flow (~2x YoY) at guidance midpoints Reiterating 2024 Adj. EBITDA $200M+ (30% margin) and $100M+ Free Cash FlowAnnouncing new $100M buyback authorization (represents ~6% of current market cap) Engaging/reaching users...

Continue reading

Man Group PLC : Form 8.3 – Barratt Developments Plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Barratt Developments plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening...

Continue reading

Dimensional Fund Advisors Ltd. : Form 8.3 – Currys plc – Ordinary Shares

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Dimensional Fund Advisors Ltd. in its capacity as investment advisor and on behalf its affiliates who are also investment advisors (”Dimensional”). Dimensional expressly disclaims beneficial ownership of the shares described in this form 8.3.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Currys...

Continue reading

The minority investments in Aspo’s subsidiary ESL Shipping by OP Finland Infrastructure and Varma have been completed

Aspo PlcPress releaseFebruary 28, 2024 at 13:00 The minority investments in Aspo’s subsidiary ESL Shipping by OP Finland Infrastructure and Varma have been completed As Aspo communicated on February 8, 2024, Varma Mutual Pension Insurance Company had agreed to co-invest EUR 15 million alongside OP Finland Infrastructure LP in Aspo’s subsidiary ESL Shipping. The co-investment by Varma follows the same valuation and terms as OP Finland Infrastructure’s EUR 30 million investment in ESL Shipping, announced on November 8, 2023. Both transactions have been completed on February 28, 2024. Aspo Plc Rolf JanssonCEO Further information, please contact: Rolf Jansson, CEO, Aspo Plc, +358 400 600 264, rolf.jansson@aspo.com Distribution:        Nasdaq HelsinkiKey mediawww.aspo.com Aspo creates value by owning and developing business operations sustainably...

Continue reading

Allarity Therapeutics to Present at Biomarkers 2024

Boston (February 28, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, is pleased to announce that it has been invited to present at Biomarkers 2024. Thomas Jensen, CEO and co-founder of Allarity, will present the company’s novel work in developing the drug-specific Drug Response Predictor (DRP®) companion diagnostics (CDx) platform. This work spans from cancer cell line research to the validation of concepts through retrospective clinical data analysis and into the area of prospective clinical trials, notably an ongoing trial for ovarian cancer. This trial investigates how a DRP® created specifically for the Company’s lead clinical asset, the dual PARP/Tankyrase inhibitor stenoparib, can be used to pre-select...

Continue reading

Verkkokauppa.com’s Annual Reporting package 2023 has been published

Verkkokauppa.com’s Annual Reporting package 2023 has been published Verkkokauppa.com Oyj                STOCK EXCHANGE RELEASE         28 February 2024 at 13:00pm EET Verkkokauppa.com has published its annual reporting package for 2023, which includes three separate publications. Together these form the company’s Annual reporting for 2023. The reporting components are the Company brochure, Report of the Board of Directors and the Financial Statements including the statement of non-financial information, and Corporate Governance statement including the Remuneration report. The Statement of non-financial information discusses the company’s sustainability work and its progress during 2023. In addition, the company will publish a separate sustainability report in the spring 2024. Verkkokauppa.com publishes the Financial Statements in accordance...

Continue reading

ACM Research Reports Fourth Quarter and Fiscal Year 2023 Results

FREMONT, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging applications, today reported financial results for its fourth quarter and fiscal year ended December 31, 2023. “2023 was another pivotal year in ACM’s mission to become a major supplier to the global semiconductor industry,” said ACM’s President and Chief Executive Officer, Dr. David Wang. “We grew revenue by 43%, well above the market growth of wafer fab equipment (WFE) spending in mainland China. We delivered improved operating margins, and made great progress with new products, new customers and plans to expand our global production capacity.” Dr. Wang continued, “We believe these results underscore the strength of ACM’s multi-product...

Continue reading

KKCG Completes Acquisition of Avenga from Oaktree and Cornerstone

LUZERN, Switzerland, Feb. 28, 2024 (GLOBE NEWSWIRE) — KKCG, a leading European investment and innovation group, announces the successful completion of its acquisition of Avenga, an end-to-end software engineering and consulting platform, previously owned by funds managed by Oaktree Capital Management, L.P. (“Oaktree”) and funds managed by Cornerstone Investment Management, L.P. (“Cornerstone”). Effective at the closing of the transaction, Avenga, a global technology platform headquartered in Germany, with 31 offices internationally, and nearly 4,000 professionals, has become a wholly owned subsidiary of KKCG. This acquisition marks a turning point in the strategic development of KKCG’s technology pillar. Commenting on the completion, Michal Tománek, Investment Director at KKCG, said, “Avenga bolsters KKCG’s presence internationally...

Continue reading

iQIYI Announces Fourth Quarter and Fiscal Year 2023 Financial Results

BEIJING, China, Feb. 28, 2024 (GLOBE NEWSWIRE) — iQIYI, Inc. (Nasdaq: IQ) (“iQIYI” or the “Company”), a leading provider of online entertainment video services in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 HighlightsTotal revenues were RMB7.7 billion (US$1.1 billion1), increasing 1% year over year. Operating income was RMB773.7 million (US$109.0 million) and operating income margin was 10%, compared to operating income of RMB783.6 million and operating income margin of 10% in the same period in 2022. Non-GAAP operating income2 was RMB927.8 million (US$130.7 million) and non-GAAP operating income margin was 12%, compared to non-GAAP operating income of RMB978.7 million and non-GAAP operating income margin of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.